REQUEST A DEMO
Total
USD $0.00
Search more companies

Zg Pharma Sp. z o.o. (Poland)

Main Activities: All Other Professional, Scientific, and Technical Services
Secondary Activities: Merchant Wholesalers, Durable Goods | Retail Trade | Other Activities Related to Credit Intermediation | Real Estate
Full name: Zg Pharma Sp. z o.o. Profile Updated: May 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Zg Pharma Sp. z o.o. is based in Poland, with the head office in Warsaw. The company operates in the All Other Professional, Scientific, and Technical Services industry. It was first established on February 25, 2015. It currently has a total number of 1 (2015) employees. Its’ total assets recorded a negative growth of 15.63%.

Headquarters
Ul. Twarda 2/4/258
Warsaw; Mazowieckie; Postal Code: 00-105

Contact Details: Purchase the Zg Pharma Sp. z o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Zg Pharma Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Zg Pharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Zg Pharma Sp. z o.o. report to view the information.
Incorporation Date:
February 25, 2015
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
99.01%
Company Performance
Financial values in the chart are available after Zg Pharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
17.16%
Net Profit (Loss) for the Period
17.16%
Total assets
-15.63%
Total equity
-5.22%
Return on Equity (ROE)
0.79%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?